What is the best option to cure patients with resistant/relapsing Hodgkin's disease?

Current stem cell research & therapy

Volumn 1, Issue 3, 2006, Pages 419-424

  Magagnoli, Massimo ^a   Balzarotti, Monica ^a   Castagna, Luca ^a   Demarco, Monica ^a   Santoro, Armando ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

DRUG RESISTANCE; HODGKIN DISEASE; HUMAN; PATHOLOGY; RECURRENT DISEASE; REVIEW; SALVAGE THERAPY; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG RESISTANCE, NEOPLASM; HEMATOPOIETIC STEM CELL MOBILIZATION; HODGKIN DISEASE; HUMANS; RECURRENCE; SALVAGE THERAPY; STEM CELL TRANSPLANTATION;

EID: 36349013328     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488806778226786     Document Type: Review

References (67)